What is Dianthus Therapeutics's change in other assets?

Dianthus Therapeutics (DNTH) reported change in other assets of $2.33M in Q1 2026.

How has Dianthus Therapeutics's change in other assets changed year-over-year?

Dianthus Therapeutics's change in other assets increased by 21.9% year-over-year, from $1.91M to $2.33M.

What does change in other assets mean?

Change in miscellaneous assets affecting operating cash flow.

Dianthus Therapeutics DNTH Change in Other Assets

Change in Other Assets at other companies

AmgenAMGN

-$8M-104%

Spyre Therapeutics, Inc.SYRE

$233K+150%

Kymera TherapeuticsKYMR

$3.57M+228%

Protagonist TherapeuticsPTGX

$1.92M+102%

Immunovant, Inc.IMVT

-$1.3M-767%

BridgeBio PharmaBBIO

$18.85M+3,770%

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's change in other assets?: Dianthus Therapeutics (DNTH) reported change in other assets of $2.33M in Q1 2026.
How has Dianthus Therapeutics's change in other assets changed year-over-year?: Dianthus Therapeutics's change in other assets increased by 21.9% year-over-year, from $1.91M to $2.33M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.